Original air date: March 16, 2016.
Panelists will discuss using Trade Secrets Law as a complement or alternative to Patent Law, particularly in areas such as Biotech and Medical Devices where patent eligibility has become more uncertain.
Elizabeth Howard from Orrick will cover recent court decisions relating to Trade Secrets in Biotech, with take-home points for the IP practitioner.
Debora Plehn-Dujowich from Prismatic Law Group will cover Trade Secrets and confidential information relating to Biosimilars.
Austin Wang from Hologic will discuss how Biotech, Medical Device and Diagnostics companies handle Trade Secrets.
Victoria Cundiff from Paul Hastings will moderate.